Development of a Serum Metabolome-Based Test for Early-Stage Detection of Multiple Cancers

被引:0
作者
Nagarkar, Rajnish [1 ]
Gopichand, Mamillapalli [2 ]
Pal, Suparna Kanti [3 ,4 ]
Gupta, Ankur [5 ,6 ]
Saquib, Najmuddin Md [5 ,6 ]
Ahmad, Ahmad [5 ]
Sagar, Ganga [5 ]
Rao, Kanury V. S. [5 ,6 ]
Siddiqui, Zaved [5 ,6 ]
Longkumer, Imliwati [7 ]
机构
[1] HCG Manavta Canc Ctr, Nasik, Maharashtra, India
[2] HealthCare Global Enterprises Ltd, City Canc Ctr, Vijayawada, India
[3] Indoriv Clin, Kolkata, India
[4] IPGME&R, Dept Radiotherapy, Kolkata, India
[5] PredOmix Technol Pvt Ltd, Gurugram, India
[6] PredOmix Hlth Sci Pvt Ltd, Singapore, Singapore
[7] North East Canc Hosp & Res Inst, Gauhati, Assam, India
关键词
artificial intelligence; cancer; metabolomics; OVERDIAGNOSIS; CHALLENGES; VALIDATION; DISCOVERY; DIAGNOSIS;
D O I
10.1002/cnr2.70042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Detection of cancer at the early stage currently offers the only viable strategy for reducing disease-related morbidity and mortality. Various approaches for multi-cancer early detection are being explored, which largely rely on capturing signals from circulating analytes shed by tumors into the blood. The fact that biomarker concentrations are limiting in the early stages of cancer, however, compromises the accuracy of these tests. We, therefore, adopted an alternate approach that involved interrogation of the serum metabolome with machine learning-based data analytics. Here, we monitored for modulations in metabolite patterns that correlated with the presence or absence of cancer. Results obtained confirmed the efficacy of this approach by demonstrating that it could detect a total of 15 cancers in women with an average accuracy of about 99%. Aims To further increase the scope of our test, we conducted an investigator-initiated clinical trial involving a total of 6445 study participants, which included both cancer patients and non-cancer volunteers. Our goal here was to maximize the number of cancers that could be detected, while also covering cancers in both females and males. Methods and Results Metabolites extracted from individual serum samples were profiled by ultra-performance liquid chromatography coupled to a high-resolution mass spectrometer using an untargeted protocol. After processing, the data were analyzed by our cancer detection machine-learning algorithm to differentiate cancer from non-cancer samples. Results revealed that our test platform could indeed detect a total of 30 cancers, covering both females and males, with an average accuracy of similar to 98%. Importantly, the high detection accuracy remained invariant across all four stages of the cancers. Conclusion Thus, our approach of integrating untargeted metabolomics with machine learning-powered data analytics offers a powerful strategy for early-stage multi-cancer detection with high accuracy.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study
    Lindahl, Lise M.
    Besenbacher, Soren
    Rittig, Anne H.
    Celis, Pamela
    Willerslev-Olsen, Andreas
    Gjerdrum, Lise M. R.
    Krejsgaard, Thorbjorn
    Johansen, Claus
    Litman, Thomas
    Woetmann, Anders
    Odum, Niels
    Iversen, Lars
    [J]. BLOOD, 2018, 131 (07) : 759 - 770
  • [42] A Chinese version of the Language Screening Test (CLAST) for early-stage stroke patients
    Yang, Hongyan
    Tian, Shenghua
    Flamand-Roze, Constance
    Gao, Ling
    Zhang, Wei
    Li, Yan
    Wang, Jiajia
    Sun, Zhou
    Su, Ying
    Zhao, Libin
    Liang, Zhihou
    [J]. PLOS ONE, 2018, 13 (05):
  • [43] Screening mammography for second breast cancers in women with history of early-stage breast cancer: factors and causes associated with non-detection
    Yeom, Yoo Kyung
    Chae, Eun Young
    Kim, Hak Hee
    Cha, Joo Hee
    Shin, Hee Jung
    Choi, Woo Jung
    [J]. BMC MEDICAL IMAGING, 2019, 19 (1)
  • [44] Bridging the gap: Advanced biosensor technologies for early-stage oral cancer diagnosis based on biomarker detection
    Aksoy, Zeynep Busra
    Il, Deniz Baran
    Celik, Dogantan
    Sengun, Dilara Nur
    Unal, Mehmet Altay
    Kaya, S. Irem
    Yilmazer, Acelya
    Ozkan, Sibel A.
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2024, 180
  • [45] Accurate screening of early-stage lung cancer based on improved ResNeXt model combined with serum Raman spectroscopy
    Leng, Hongyong
    Chen, Cheng
    Si, Rumeng
    Chen, Chen
    Qu, Hanwen
    Lv, Xiaoyi
    [J]. JOURNAL OF RAMAN SPECTROSCOPY, 2022, 53 (07) : 1302 - 1311
  • [46] Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis
    Castillo-Trivino, Tamara
    Gomez-Ballesteros, Rocio
    Borges, Monica
    Martin-Martinez, Jesus
    Sotoca, Javier
    Alonso, Ana
    Caminero, Ana B.
    Borrega, Laura
    Sanchez-Menoyo, Jose L.
    Barrero-Hernandez, Francisco J.
    Calles, Carmen
    Brieva, Luis
    Blasco-Quilez, Maria R.
    Garcia-Soto, Julio Dotor
    del Campo-Amigo, Maria
    Navarro-Canto, Laura
    Aguera, Eduardo
    Garces-Redondo, Moises
    Carmona, Olga
    Gabaldon-Torres, Laura
    Forero, Lucia
    Hervas, Mariona
    Maurino, Jorge
    de la Maza, Susana Sainz
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 64
  • [47] A Bayesian belief network-based analytics methodology for early-stage risk detection of novel diseases
    Topuz, Kazim
    Davazdahemami, Behrooz
    Delen, Dursun
    [J]. ANNALS OF OPERATIONS RESEARCH, 2024, 341 (01) : 673 - 697
  • [48] Combined chemoradiotherapy showed improved outcome with early-stage HPV-positive oropharyngeal cancers
    Lu, X. J. David
    Jackson, Emmanuel
    Chew, Jason
    Nguyen, Sally
    Wu, Jonn
    Poh, Catherine F.
    Prisman, Eitan
    [J]. BMC CANCER, 2022, 22 (01)
  • [49] Racial Differences in Oncogene Mutations Detected in Early-Stage Low-Grade Endometrial Cancers
    Cote, Michele L.
    Atikukke, Govindaraja
    Ruterbusch, Julie J.
    Olson, Sara H.
    Sealy-Jefferson, Shawnita
    Rybicki, Benjamin A.
    Alford, Sharon Hensley
    Elshaikh, Mohammad A.
    Gaba, Arthur R.
    Schultz, Daniel
    Haddad, Ramsi
    Munkarah, Adnan R.
    Ali-Fehmi, Rouba
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (08) : 1367 - 1372
  • [50] HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinoma
    Bai, Yi
    Xu, Juan
    Li, Deqiang
    Zhang, Xiaoyu
    Chen, Dapeng
    Xie, Fucun
    Huang, Longmei
    Yu, Xiaotian
    Zhao, Haitao
    Zhang, Yamin
    [J]. CLINICAL EPIGENETICS, 2023, 15 (01)